Items where Author is "Mouridsen, H."
Number of items: 2. 2011Viale, G. and Regan, M. M. and Dell'Orto, P. and Mastropasqua, M. G. and Maiorano, E. and Rasmussen, B. B. and MacGrogan, G. and Forbes, J. F. and Paridaens, R. J. and Colleoni, M. and Láng, I. and Thürlimann, B. and Mouridsen, H. and Mauriac, L. and Gelber, R. D. and Price, K. N. and Goldhirsch, A. and Gusterson, B. A. and Coates, A. S. and International Breast Cancer Study Groups, . (2011) Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial. Annals of oncology, Vol. 22, H. 10. pp. 2201-2207. 2009Rabaglio, M. and Sun, Z. and Price, K. N. and Castiglione-Gertsch, M. and Hawle, H. and Thürlimann, B. and Mouridsen, H. and Campone, M. and Forbes, J. F. and Paridaens, R. J. and Colleoni, M. and Pienkowski, T. and Nogaret, J.-M. and Láng, I. and Smith, I. and Gelber, R. D. and Goldhirsch, A. and Coates, A. S.. (2009) Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 20. pp. 1489-1498. |
